Berger Financial Group Inc Sells 226 Shares of iShares Biotechnology ETF $IBB

Berger Financial Group Inc lessened its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.6% in the second quarter, HoldingsChannel reports. The fund owned 2,754 shares of the financial services provider’s stock after selling 226 shares during the period. Berger Financial Group Inc’s holdings in iShares Biotechnology ETF were worth $348,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently made changes to their positions in the company. QRG Capital Management Inc. boosted its stake in iShares Biotechnology ETF by 5.3% in the 2nd quarter. QRG Capital Management Inc. now owns 2,437 shares of the financial services provider’s stock valued at $308,000 after purchasing an additional 123 shares during the period. Washington Growth Strategies LLC boosted its position in shares of iShares Biotechnology ETF by 4,996.9% in the second quarter. Washington Growth Strategies LLC now owns 6,524 shares of the financial services provider’s stock valued at $825,000 after acquiring an additional 6,396 shares during the period. Ping Capital Management Inc. boosted its position in shares of iShares Biotechnology ETF by 14.3% in the second quarter. Ping Capital Management Inc. now owns 8,000 shares of the financial services provider’s stock valued at $1,012,000 after acquiring an additional 1,000 shares during the period. Generali Investments CEE investicni spolecnost a.s. grew its stake in shares of iShares Biotechnology ETF by 35.0% in the second quarter. Generali Investments CEE investicni spolecnost a.s. now owns 116,115 shares of the financial services provider’s stock valued at $14,690,000 after acquiring an additional 30,115 shares in the last quarter. Finally, Sound Income Strategies LLC increased its position in iShares Biotechnology ETF by 330.9% during the second quarter. Sound Income Strategies LLC now owns 823 shares of the financial services provider’s stock worth $104,000 after acquiring an additional 632 shares during the period. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Down 0.3%

Shares of iShares Biotechnology ETF stock opened at $150.52 on Tuesday. iShares Biotechnology ETF has a twelve month low of $107.43 and a twelve month high of $151.79. The company has a 50-day simple moving average of $139.51 and a two-hundred day simple moving average of $130.07.

iShares Biotechnology ETF Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 19th. Investors of record on Tuesday, September 16th were paid a $0.0828 dividend. This represents a $0.33 annualized dividend and a dividend yield of 0.2%. The ex-dividend date was Tuesday, September 16th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.